臨床栄養のアジア太平洋市場2020-2026:投与経路別(経口、経腸、非経口)、用途別、地域別

◆英語タイトル:Asia Pacific Clinical Nutrition Market By Route of Administration (Oral, Enteral and Parenteral) By Application (Cancer, Neurological Diseases, Gastrointestinal Disorders, Metabolic Disorders and Other Applications) By Country, Industry Analysis and Forecast, 2020 - 2026
◆商品コード:KBV20OCT213
◆発行会社(リサーチ会社):KBV Research
◆発行日:2020年5月31日
◆ページ数:104
◆レポート言語:英語
◆レポート形式:PDF
◆納品方法:Eメール
◆調査対象地域:中国、日本、インド、韓国、シンガポール、マレーシア
◆販売価格オプション(消費税別)
Single User(1名様利用)USD1,500 ⇒換算¥162,000見積依頼/購入/質問フォーム
Global License(法人利用)USD2,520 ⇒換算¥272,160見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日~2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送しますので、請求書発行日より2ヶ月以内に振込をお願いします。
※上記の日本語題名はH&Iグローバルリサーチが翻訳したものです。英語版原本には日本語表記はありません。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はKBV Research社の日本における正規販売代理店です。同社発行の医療分野調査レポートに関するお問い合わせは弊社までお願い致します。
KBV Research社の概要はこちらでご確認いただけます。
※上記「見積依頼/購入/質問フォーム」をクリックすると弊社運営のレポート販売サイトに移動します。

本市場調査レポートでは、臨床栄養のアジア太平洋市場について、市場範囲・調査手法、市場概要、競争分析、投与経路別(経口、経腸、非経口)、用途別分析、地域別分析、企業概要などを総合的、多面的に調査・分析しました。
・市場範囲・調査手法
・市場概要
・競争分析
・臨床栄養のアジア太平洋市場規模:投与経路別(経口、経腸、非経口)
・臨床栄養のアジア太平洋市場規模:用途別
・臨床栄養のアジア太平洋市場規模:地域別
・企業概要
【レポートの概要】

The Asia Pacific Clinical Nutrition Market would witness market growth of 8.2% CAGR during the forecast period (2020-2026).

Increased prevalence of chronic disorders, and increased numbers of patients using advanced clinical nutrition products, leading towards the growth of the clinical nutrition industry. Increased government R&D investments in health care are also some of the key factors driving the global market for clinical nutrition. The clinical nutrition industry is however hindered by a lack of knowledge and strict regulations. In addition, increased progress in clinical nutrition is expected to offer profitability to global clinical nutrition market players and the growth of various growth opportunities for clinical nutritional products in emerging countries.

Asia-Pacific is expected to grow at the highest growth over the forecast period. The key factors contributing to the growth of the Asia-Pacific clinical nutrition market include a rise in the prevalence of metabolic disorders, an expansion in the geriatric population in the Asia-Pacific region, as well as extensive healthcare spending. The prevalence of diabetes in China is also growing rapidly, which is a major factor in obesity. The actual number of patients diagnosed with metabolic disorders has increased over the last decade, increasing the number of patients diagnosed in the Asia Pacific region.

Most metabolic syndromes lead to situations where the body cannot synthesize non-essential molecules, such as vitamins, amino acids, and several molecules involved in metabolic pathways. Most of these conditions can only be managed with the addition of one or two nutrients. All of these factors are helping the growth of the market. There are, however, few factors that may restrict the market growth.

Based on Route of Administration, the market is segmented into Oral, Enteral and Parenteral. Based on Application, the market is segmented into Cancer, Neurological Diseases, Gastrointestinal Disorders, Metabolic Disorders and Other Applications. Based on countries, the market is segmented into China, Japan, India, South Korea, Singapore, Malaysia, and Rest of Asia Pacific.

The market research report covers theanalysis of key stake holders of the market. Key companies profiled in the report include Abbott Laboratories, B. Braun Melsungen AG, Baxter International, Inc., Pfizer, Inc., Nestle S.A., Lonza Group AG, BASF SE, Ajinomoto Co., Inc., Perrigo Company PLC, and Hero Nutritionals, Inc.

Scope of the Study
Market Segmentation:

By Route of Administration
• Oral
• Enteral and
• Parenteral

By Application
• Cancer
• Neurological Diseases
• Gastrointestinal Disorders
• Metabolic Disorders and
• Other Applications

By Country
• China
• Japan
• India
• South Korea
• Singapore
• Malaysia
• Rest of Asia Pacific

Companies Profiled
• Abbott Laboratories
• B. Braun Melsungen AG
• Baxter International, Inc.
• Pfizer, Inc.
• Nestle S.A.
• Lonza Group AG
• BASF SE
• Ajinomoto Co., Inc.
• Perrigo Company PLC
• Hero Nutritionals, Inc.

Unique Offerings from KBV Research
• Exhaustive coverage
• Highest number of market tables and figures
• Subscription based model available
• Guaranteed best price
• Assured post sales research support with 10% customization free

【レポートの目次】

Chapter 1. Market Scope & Methodology
1.1 Market Definition
1.2 Objectives
1.3 Market Scope
1.4 Segmentation
1.4.1 Asia Pacific Clinical Nutrition Market, by Route of Administration
1.4.2 Asia Pacific Clinical Nutrition Market, by Application
1.4.3 Asia Pacific Clinical Nutrition Market, by Country
1.5 Methodology for the research
Chapter 2. Market Overview
2.1 Introduction
2.1.1 Overview
2.1.2 Market Composition and Scenario
2.2 Key Factors Impacting the Market
2.2.1 Market Drivers
2.2.2 Market Restraints
Chapter 3. Competition Analysis – Global
3.1 KBV Cardinal Matrix
3.2 Recent Industry Wide Strategic Developments
3.2.1 Partnerships, Collaborations and Agreements
3.2.2 Product Launches and Product Expansions
3.2.3 Mergers & Acquisitions
3.2.4 Geographical Expansions
3.3 Top Winning Strategies
3.3.1 Key Leading Strategies: Percentage Distribution (2016-2020)
3.3.2 Key Strategic Move: (Partnerships, Collaborations, and Agreements : 2016, Jan – 2019, Dec) Leading Players
3.3.3 Key Strategic Move: (Product Launches and Product Expansions : 2016, Mar – 2019, Oct) Leading Players
Chapter 4. Asia Pacific Clinical Nutrition Market by Route Of Administration
4.1 Asia Pacific Oral Market by Country
4.2 Asia Pacific Enteral Market by Country
4.3 Asia Pacific Parenteral Market by Country
Chapter 5. Asia Pacific Clinical Nutrition Market by Application
5.1 Asia Pacific Cancer Market by Country
5.2 Asia Pacific Neurological Diseases Market by Country
5.3 Asia Pacific Gastrointestinal Disorders Market by Country
5.4 Asia Pacific Metabolic Disorders Market by Country
5.5 Asia Pacific Other Applications Market by Country
Chapter 6. Asia Pacific Clinical Nutrition Market by End User
6.1 Asia Pacific Adults Clinical Nutrition Market by Country
6.2 Asia Pacific Pediatric Market by Country
6.3 Asia Pacific Geriatric Market by Country
Chapter 7. Asia Pacific Clinical Nutrition Market by Country
7.1 China Clinical Nutrition Market
7.1.1 China Clinical Nutrition Market by Route Of Administration
7.1.2 China Clinical Nutrition Market by Application
7.1.3 China Clinical Nutrition Market by End User
7.2 Japan Clinical Nutrition Market
7.2.1 Japan Clinical Nutrition Market by Route Of Administration
7.2.2 Japan Clinical Nutrition Market by Application
7.2.3 Japan Clinical Nutrition Market by End User
7.3 India Clinical Nutrition Market
7.3.1 India Clinical Nutrition Market by Route Of Administration
7.3.2 India Clinical Nutrition Market by Application
7.3.3 India Clinical Nutrition Market by End User
7.4 South Korea Clinical Nutrition Market
7.4.1 South Korea Clinical Nutrition Market by Route Of Administration
7.4.2 South Korea Clinical Nutrition Market by Application
7.4.3 South Korea Clinical Nutrition Market by End User
7.5 Singapore Clinical Nutrition Market
7.5.1 Singapore Clinical Nutrition Market by Route Of Administration
7.5.2 Singapore Clinical Nutrition Market by Application
7.5.3 Singapore Clinical Nutrition Market by End User
7.6 Malaysia Clinical Nutrition Market
7.6.1 Malaysia Clinical Nutrition Market by Route Of Administration
7.6.2 Malaysia Clinical Nutrition Market by Application
7.6.3 Malaysia Clinical Nutrition Market by End User
7.7 Rest of Asia Pacific Clinical Nutrition Market
7.7.1 Rest of Asia Pacific Clinical Nutrition Market by Route Of Administration
7.7.2 Rest of Asia Pacific Clinical Nutrition Market by Application
7.7.3 Rest of Asia Pacific Clinical Nutrition Market by End User
Chapter 8. Company Profiles
8.1 Abbott Laboratories
8.1.1 Company Overview
8.1.2 Financial Analysis
8.1.3 Segmental and Regional Analysis
8.1.4 Research & Development Expense
8.1.5 Recent strategies and developments:
8.1.5.1 Acquisition and Mergers:
8.1.5.2 Product Launches and Product Expansions:
8.2 B. Braun Melsungen AG
8.2.1 Company Overview
8.2.2 Financial Analysis
8.2.3 Segmental Analysis
8.2.4 Research & Development Expense
8.2.5 Recent strategies and developments:
8.2.5.1 Product Launches and Product Expansions:
8.2.5.2 Partnerships, Collaborations, and Agreements:
8.3 Baxter International, Inc.
8.3.1 Company Overview
8.3.2 Financial Analysis
8.3.3 Regional Analysis
8.3.4 Research & Development Expense
8.3.5 Recent strategies and developments:
8.3.5.1 Product Launches and Product Expansions:
8.4 Pfizer, Inc.
8.4.1 Company Overview
8.4.2 Segmental and Regional Analysis
8.4.3 Research & Development Expense
8.4.4 Recent strategies and developments:
8.4.4.1 Acquisition and Mergers:
8.5 Nestle S.A.
8.5.1 Company Overview
8.5.2 Financial Analysis
8.5.3 Segmental and Regional Analysis
8.5.4 Research& Development Expense
8.5.5 Recent strategies and developments:
8.5.5.1 Partnerships, Collaborations, and Agreements:
8.5.5.2 Product Launches and Product Expansions:
8.5.5.3 Geographical Expansions:
8.6 Lonza Group AG
8.6.1 Company Overview
8.6.2 Financial Analysis
8.6.3 Segmental and Regional Analysis
8.6.4 Research & Development Expense
8.6.5 Recent strategies and developments:
8.6.5.1 Partnerships, Collaborations, and Agreements:
8.6.5.2 Product Launches and Product Expansions:
8.6.5.3 Acquisition and Mergers:
8.7 BASF SE
8.7.1 Company Overview
8.7.2 Financial Analysis
8.7.3 Segmental and Regional Analysis
8.7.4 Research & Development Expense
8.7.5 Recent strategies and developments:
8.7.5.1 Partnerships, Collaborations, and Agreements:
8.8 Ajinomoto Co., Inc.
8.8.1 Company Overview
8.8.2 Financial Analysis
8.8.3 Segmental & Regional Analysis
8.8.4 Research & Development Expenses
8.8.5 Recent strategies and developments:
8.8.5.1 Partnerships, Collaborations, and Agreements:
8.8.5.2 Acquisition and Mergers:
8.9 Perrigo Company PLC
8.9.1 Company Overview
8.9.2 Financial Analysis
8.9.3 Segmental and Regional Analysis
8.9.4 Research & Development Expense
8.1 Hero Nutritionals, Inc.
8.10.1 Company Overview



【免責事項】
https://www.marketreport.jp/reports-disclaimer

★医療情報レポート[臨床栄養のアジア太平洋市場2020-2026:投与経路別(経口、経腸、非経口)、用途別、地域別]についてメールでお問い合わせはこちら



◆H&Iグローバルリサーチ株式会社のお客様(例)◆